About Good Therapeutics

What does Good Therapeutics do?

Good Therapeutics is a provider of self-regulating, context-dependent protein therapeutics that sense biomarkers and activate in the tumor microenvironment. Portfolio includes ATP-IFNα, ATP-IL12, PD1-IL12, LAG3-IL2, LRRC15-IFNα, and LRRC15-antiTGFβR2, designed to drive anti-tumor immunity, deliver IL-12 while blocking PD-1/PD-L1 signaling, target cancer-associated fibroblasts, and minimize systemic toxicity.

Who are Good Therapeutics's competitors?

Good Therapeutics's competitors and similar companies include Linnaeus Therapeutics, iOmx Therapeutics, YM BioSciences, Fabrus, and ME Therapeutics.

Where is Good Therapeutics headquartered?

Good Therapeutics is headquartered in United States.

How many employees does Good Therapeutics have?

Good Therapeutics has 1,000 employees 🔒.

When was Good Therapeutics founded?

Good Therapeutics was founded in 2010 🔒.

What sector and industry vertical is Good Therapeutics in?

Good Therapeutics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Good Therapeutics

Who are the top strategic acquirers in Good Therapeutics's sector and industry

Top strategic M&A buyers and acquirers in Good Therapeutics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Good Therapeutics?

Top strategic M&A buyers groups and sectors for Good Therapeutics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Good Therapeutics's sector and industry vertical

Which are the top PE firms investing in Good Therapeutics's sector and industry vertical?

Top PE firms investing in Good Therapeutics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Good Therapeutics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Good Therapeutics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Good Therapeutics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Good Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Good Therapeutics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Good Therapeutics?

The key public trading comparables and valuation benchmarks for Good Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Good Therapeutics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Good Therapeutics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Good Therapeutics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Good Therapeutics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Good Therapeutics's' sector and industry vertical?

Access recent funding rounds and capital raises in Good Therapeutics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.